Paul Touhey

Paul has more than 25 years of medical device industry experience. He is currently the Executive Chairman of Invisible Sentinel Inc., a molecular diagnostics company. He serves as Chairman of the Board of Directors of TELA Bio, Inc., and is on the Board of Directors of Cytovas, a company focused on predicting cardiovascular events.

Paul is the former President/CEO and member of the Board of Directors of Fujirebio Diagnostics, Inc. (FDI), the world’s premier cancer diagnostics company. Paul joined FDI in 1998 when Fujirebio acquired the Diagnostics Division of Centocor Inc. He joined Centocor in 1985 and held a variety of positions including Senior Vice President of Operations. Prior to FDI and Centocor, Paul worked for Johnson & Johnson in a variety of positions with increasing levels of responsibility and management.

Paul received his Bachelor of Arts degree in Political Science from Temple University and has chaired and or is a current member of numerous industry trade associations and philanthropic organizations and continues to serve as an Advisor to Fujirebio.